pembrolizumab 100 MG in 4 ML Injection
- RxCUI
- 1657750
- RxNorm name
- pembrolizumab 100 MG in 4 ML Injection
- Display name
- pembrolizumab 100 MG in 4 ML Injection
- Full name
- pembrolizumab 100 MG in 4 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125514 | Keytruda | pembrolizumab | 351(a) | Disc | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KEYTRUDA | PEMBROLIZUMAB | Merck Sharp & Dohme LLC | 9333c79b-d487-4538-a9f0-71b91a02b287 | 2026-07-10 | Warnings, Adverse reactions | 1657750 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9333c79b-d487-4538-a9f0-71b91a02b287 | pembrolizumab 100 MG in 4 ML Injection | PSN | 225 | These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014 | 20260512 |
| 9333c79b-d487-4538-a9f0-71b91a02b287 | pembrolizumab 100 MG per 4 ML Injection | SY | 225 | These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014 | 20260512 |
| 9333c79b-d487-4538-a9f0-71b91a02b287 | 4 ML pembrolizumab 25 MG/ML Injection | SCD | 225 | These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014 | 20260512 |